Ming-Ming He
Impact in
- Cancer Research top 5%
- Cancer Genomics and Diagnostics
- Cancer, Lipids, and Metabolism
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Colorectal Cancer Treatments and Studies
- Inflammatory Biomarkers in Disease Prognosis
Papers in ⓘ
- Oncology 24
- Colorectal Cancer Treatments and Studies 12
- Cancer Immunotherapy and Biomarkers 6
- Colorectal Cancer Screening and Detection 4
-
- Cancer Genomics and Diagnostics 7
- Cancer, Lipids, and Metabolism 3
- Co-authors
- Rui‐Hua Xu (20 shared papers)Feng Wang (16 shared papers)Ying Jin (11 shared papers)Qi Zhao (7 shared papers)Zexian Liu (3 shared papers)Ying-Nan Wang (1 shared paper)Hui Luo (12 shared papers)Mingyang Song (7 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Cell Reports Medicine (2 papers)Gut (2 papers)Annals of Oncology (2 papers)Epidemiology and Infection (2 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Ming-Ming He
47 papers receiving 1.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Cancer Research 381
- Oncology 634
- Pathology and Forensic Medicine 215
- Pulmonary and Respiratory Medicine 315
- Microbiology 39
Countries citing papers authored by Ming-Ming He
This map shows the geographic impact of Ming-Ming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming-Ming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming-Ming He more than expected).
Fields of papers citing papers by Ming-Ming He
This network shows the impact of papers produced by Ming-Ming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming-Ming He. The network helps show where Ming-Ming He may publish in the future.
Co-authors
The 25 scholars most cited alongside Ming-Ming He, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 49 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Evaluation of POLE and POLD1 Mutations as Biomarkers for Immunotherapy Outcomes Across Multiple Cancer Types Hit paper breakdown → | 2019 | 280 |
| 2 | 2015 | 140 | |
| 3 | 2021 | 108 | |
| 4 | 2019 | 89 | |
| 5 | 2020 | 79 | |
| 6 | 2021 | 68 | |
| 7 | 2020 | 49 | |
| 8 | 2020 | 48 | |
| 9 | 2019 | 39 | |
| 10 | 2022 | 37 | |
| 11 | Anti-PD-1 antibody SHR-1210 plus apatinib for metastatic colorectal cancer: a prospective, single-arm, open-label, phase II trial. | 2020 | 32 |
| 12 | 2021 | 32 | |
| 13 | 2023 | 29 | |
| 14 | 2022 | 24 | |
| 15 | 2019 | 22 | |
| 16 | 2013 | 21 | |
| 17 | 2018 | 20 | |
| 18 | 2014 | 18 | |
| 19 | 2015 | 17 | |
| 20 | 2012 | 16 |
About Ming-Ming He
Ming-Ming He is a scholar working on Oncology, Cancer Research, Gastroenterology, Pulmonary and Respiratory Medicine and Microbiology, having authored 49 papers that have together received 1.3k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (12 papers), Gastric Cancer Management and Outcomes (11 papers), Cancer Genomics and Diagnostics (7 papers), Cancer Immunotherapy and Biomarkers (6 papers), Pneumonia and Respiratory Infections (4 papers), Colorectal Cancer Screening and Detection (4 papers), Genetic factors in colorectal cancer (3 papers) and Cancer, Lipids, and Metabolism (3 papers). The work is most often cited by research in Cancer Research (381 citations), Oncology (634 citations), Pathology and Forensic Medicine (215 citations), Pulmonary and Respiratory Medicine (315 citations) and Microbiology (39 citations). Ming-Ming He has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Rui‐Hua Xu, Feng Wang, Ying Jin, Qi Zhao, Zexian Liu, Ying-Nan Wang, Hui Luo, Mingyang Song, Zhe Fang and Chao Ren. Their work appears in journals such as Journal of Clinical Oncology, Cell Reports Medicine, Gut, Annals of Oncology and Epidemiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.